SCHEMBL18954709

SCHEMBL18954709

O=C(O)c1ccccc1CN1C(=O)C(=O)c2cc(F)c(Cl)cc21

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ CHRM5 P08912 3/20 0.48
▸ CA12 O43570 3/20 0.48
▸ CA1 P00915 3/20 0.48
▸ CA2 P00918 3/20 0.48
▸ CA9 Q16790 3/20 0.48
▸ ALDH1A1 P00352 5/20 0.47
▸ ALDH2 P05091 4/20 0.47
▸ ALDH3A1 P30838 4/20 0.47
▸ PARK7 Q99497 2/20 0.46
▸ PRKAG1 P54619 1/20 0.44
▸ PRKAA2 P54646 1/20 0.44
▸ PRKAB1 Q9Y478 1/20 0.44
▸ CES1 P23141 2/20 0.43
▸ CHRM1 P11229 1/20 0.43
▸ APAF1 O14727 1/20 0.43
▸ TP53 P04637 1/20 0.43
▸ CYP1A2 P05177 1/20 0.43
▸ BCHE P06276 1/20 0.43
▸ CYP3A4 P08684 1/20 0.43
▸ CYP2D6 P10635 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18954774 0.83 CHRM5 (0.66) CHRM5CA12CA1CA2CA9
SCHEMBL18954793 0.83 ALDH3A1 (0.69) CHRM5CA12CA1CA2CA9
SCHEMBL18954674 0.82 CHRM5 (0.55) CHRM5CA12CA1CA2CA9
SCHEMBL18974327 0.80 CES1 (0.62) CHRM5ALDH1A1ALDH2ALDH3A1PARK7
SCHEMBL18954751 0.78 ALDH1A1 (0.67) CHRM5CA12CA1CA2CA9
SCHEMBL18954858 0.78 ACHE (0.63) CHRM5ALDH1A1ALDH2ALDH3A1PARK7
SCHEMBL18955172 0.78 CTRC (0.54) CHRM5CA12CA1CA2CA9
SCHEMBL18954828 0.78 CHRM5 (0.54) CHRM5CA12CA1CA2CA9
SCHEMBL18954872 0.78 CHRM5 (0.55) CHRM5ALDH1A1ALDH2ALDH3A1PARK7
SCHEMBL18954567 0.77 ALDH1A1 (0.55) CHRM5ALDH1A1ALDH2ALDH3A1PARK7

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2017099695-A1 N-[(AMINOSULFONYL)PHENYL]-2-(1,2-DIHYDRO-2-OXO-3H-INDOL-3-YLIDENE)-HYDRAZINECARBOTHIOAMIDE DERIVATIVES FOR TREATING CANCER AND IMMUNOLOGICAL DISORDERS ISTANBUL UNIVERSITESI REKTORLUGU (TR) 2017-06-15 — — WO disclosed
Send feedback